Arcadia Biosciences Stock Performance
| RKDA Stock | USD 1.68 0.06 3.45% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Arcadia Biosciences are completely uncorrelated. At this point, Arcadia Biosciences has a negative expected return of -1.13%. Please make sure to confirm Arcadia Biosciences' information ratio, daily balance of power, period momentum indicator, as well as the relationship between the value at risk and day typical price , to decide if Arcadia Biosciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Arcadia Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Last Split Factor 1:40 | Dividend Date 2018-01-24 | Last Split Date 2023-03-01 |
1 | Is Arcadia Biosciences Inc. stock a smart buy before Fed meeting - newser.com | 11/19/2025 |
2 | Can Arcadia Biosciences Inc. stock hit record highs again - July 2025 Retail Reliable Trade Execution Plans - | 12/18/2025 |
3 | Arcadia Biosciences Stockholders Back Directors and Governance Moves - TipRanks | 12/23/2025 |
4 | RKDA stock rises pre-market after company receives merger termination notice from Roosevelt Resources - MSN | 01/02/2026 |
5 | Arcadia Biosciences Announces Exercise of Preferred Investment Options for 2.1 Million Gross Proceeds | 01/12/2026 |
| Begin Period Cash Flow | 6.5 M | |
| Total Cashflows From Investing Activities | 7.3 M |
Arcadia Biosciences Relative Risk vs. Return Landscape
If you would invest 371.00 in Arcadia Biosciences on November 18, 2025 and sell it today you would lose (203.00) from holding Arcadia Biosciences or give up 54.72% of portfolio value over 90 days. Arcadia Biosciences is currently does not generate positive expected returns and assumes 5.5557% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Arcadia, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Arcadia Biosciences Target Price Odds to finish over Current Price
The tendency of Arcadia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.68 | 90 days | 1.68 | more than 93.0 |
Based on a normal probability distribution, the odds of Arcadia Biosciences to move above the current price in 90 days from now is more than 93.0 (This Arcadia Biosciences probability density function shows the probability of Arcadia Stock to fall within a particular range of prices over 90 days) .
Arcadia Biosciences Price Density |
| Price |
Predictive Modules for Arcadia Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Arcadia Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arcadia Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arcadia Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Arcadia Biosciences is not an exception. The market had few large corrections towards the Arcadia Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Arcadia Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Arcadia Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.79 | |
Ir | Information ratio | -0.2 |
Arcadia Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Arcadia Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Arcadia Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Arcadia Biosciences generated a negative expected return over the last 90 days | |
| Arcadia Biosciences has high historical volatility and very poor performance | |
| Arcadia Biosciences may become a speculative penny stock | |
| Arcadia Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.04 M. Net Loss for the year was (4.32 M) with profit before overhead, payroll, taxes, and interest of 2.09 M. | |
| Arcadia Biosciences currently holds about 21.23 M in cash with (9.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96. | |
| Arcadia Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Does IT Tech Packaging Inc. have pricing power - July 2025 Weekly Recap Long Hold Capital Preservation Plans - mfd.ru |
Arcadia Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Arcadia Stock often depends not only on the future outlook of the current and potential Arcadia Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arcadia Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.4 M | |
| Cash And Short Term Investments | 4.2 M |
Arcadia Biosciences Fundamentals Growth
Arcadia Stock prices reflect investors' perceptions of the future prospects and financial health of Arcadia Biosciences, and Arcadia Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arcadia Stock performance.
| Return On Equity | -0.65 | ||||
| Return On Asset | -0.31 | ||||
| Profit Margin | (0.98) % | ||||
| Operating Margin | (0.88) % | ||||
| Current Valuation | (1.53 M) | ||||
| Shares Outstanding | 1.73 M | ||||
| Price To Earning | 4.84 X | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 0.71 X | ||||
| Revenue | 5.04 M | ||||
| Gross Profit | 2.09 M | ||||
| EBITDA | (7.5 M) | ||||
| Net Income | (4.32 M) | ||||
| Cash And Equivalents | 21.23 M | ||||
| Cash Per Share | 0.96 X | ||||
| Total Debt | 155 K | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 6.34 X | ||||
| Book Value Per Share | 3.98 X | ||||
| Cash Flow From Operations | (9.63 M) | ||||
| Earnings Per Share | (3.69) X | ||||
| Market Capitalization | 3.66 M | ||||
| Total Asset | 13.52 M | ||||
| Retained Earnings | (278.88 M) | ||||
| Working Capital | 6.68 M | ||||
| Current Asset | 52.02 M | ||||
| Current Liabilities | 3.45 M | ||||
About Arcadia Biosciences Performance
By analyzing Arcadia Biosciences' fundamental ratios, stakeholders can gain valuable insights into Arcadia Biosciences' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Arcadia Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Arcadia Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 100.22 | 189.10 | |
| Return On Tangible Assets | (0.47) | (0.49) | |
| Return On Capital Employed | (0.30) | (0.31) | |
| Return On Assets | (0.47) | (0.49) | |
| Return On Equity | (1.30) | (1.24) |
Things to note about Arcadia Biosciences performance evaluation
Checking the ongoing alerts about Arcadia Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Arcadia Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Arcadia Biosciences generated a negative expected return over the last 90 days | |
| Arcadia Biosciences has high historical volatility and very poor performance | |
| Arcadia Biosciences may become a speculative penny stock | |
| Arcadia Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 5.04 M. Net Loss for the year was (4.32 M) with profit before overhead, payroll, taxes, and interest of 2.09 M. | |
| Arcadia Biosciences currently holds about 21.23 M in cash with (9.63 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.96. | |
| Arcadia Biosciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Does IT Tech Packaging Inc. have pricing power - July 2025 Weekly Recap Long Hold Capital Preservation Plans - mfd.ru |
- Analyzing Arcadia Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arcadia Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Arcadia Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arcadia Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arcadia Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arcadia Biosciences' stock. These opinions can provide insight into Arcadia Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Arcadia Stock analysis
When running Arcadia Biosciences' price analysis, check to measure Arcadia Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcadia Biosciences is operating at the current time. Most of Arcadia Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcadia Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcadia Biosciences' price. Additionally, you may evaluate how the addition of Arcadia Biosciences to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |